Key Points:
- India and the UK sign a major free trade deal, slashing tariffs on 99% of Indian exports and easing market access.
- Textile, seafood, auto parts, and pharma stocks rally, while the overall market shows caution amid global uncertainties.
- Deal expected to boost $34B in annual trade and generate millions of jobs, especially in MSMEs and labour-intensive sectors.
In a historic move, India and the United Kingdom have finalized a Comprehensive Economic and Trade Agreement (CETA)—India’s first major free trade pact outside Asia and the UK’s most significant trade deal post-Brexit. Signed during Prime Minister Narendra Modi’s state visit to London, the agreement slashes tariffs on 99% of Indian exports, including key categories such as textiles, leather goods, auto components, processed foods, seafood, and gems and jewellery.
The UK Trade Deal also reduces import duties on UK products like cars, whisky, and gin, with phased cuts lowering Indian tariffs from up to 150% to 75%, and eventually less. Beyond goods, the agreement offers India access to the UK’s £38 billion government procurement market and facilitates professional mobility by easing visa requirements and social security obligations.
According to Indian trade officials, the agreement could boost bilateral trade by $34 billion annually, with ambitions to reach $120 billion by 2030. The pact is also expected to create millions of jobs, particularly in MSMEs and labour-intensive sectors, underscoring its strategic alignment with India’s “Make in India” initiative.
Market Response Mixed as Export Stocks Gain but Index Weakens
Despite the long-term optimism, Indian equity markets posted a muted reaction. On July 25, 2025, the Sensex fell over 550 points, and the Nifty slipped below the 24,900 mark, largely due to weakness in heavyweight stocks and global volatility.
However, export-oriented sectors saw selective bullish momentum. Textile and seafood exporters rallied sharply on expectations of tariff-free UK trade deal access. Gift Nifty futures hovered near the flatline, indicating investor caution amid other ongoing trade discussions—particularly with the United States, where pharma and generic drug exporters face mounting pressure from protectionist rhetoric.
According to analysts, the FTA will benefit specific segments in the long term, but broader market enthusiasm remains tempered until there is more clarity on India’s trade trajectory with the US and Europe. External factors, including oil prices, global bond yields, and currency movements, also influenced trading sentiment.
Sector Winners Identified—Top Stocks Poised for UK trade deal Windfall
Financial analysts identified 10 Indian stocks poised to gain from the India-UK FTA, spanning textiles, auto components, pharmaceuticals, and seafood. Notably, Trident Ltd surged nearly 6%, while SP Apparels, Redtape, and TCNS Clothing recorded notable gains on optimism about easier UK market access.
The seafood and processed food sector, previously subjected to duties as high as 70%, is also expected to flourish. With the UK importing over $5.4 billion in seafood annually, Indian marine exporters are now positioned to scale exports significantly. Experts note this shift could benefit over 28 million workers in the coastal and food-processing sectors, many of them women.
In the pharmaceutical and medical device space, zero-duty access is expected to accelerate growth. India’s pharma exports to the UK, valued at approximately $914 million in FY24, are already growing at an 18% annual rate and could now see further expansion. However, the industry remains cautious due to rising uncertainty in US trade policy, which could impact generics and bulk drug shipments.
The India-UK trade deal marks a strategic breakthrough for both nations, promising substantial economic gains, especially for Indian MSMEs and labour-intensive sectors. While export-driven stocks show early signs of optimism, broader market sentiment remains sensitive to global cues and the outcome of pending trade talks—particularly with the US. In the coming months, investor focus will remain on policy clarity, earnings momentum, and trade-linked sectoral performance.